Hyundai Asset Management Lists 'UNICORN KOSDAQ Bio Active' ETF

Hyundai Asset Management announced on May 12 that it has listed the 'UNICORN KOSDAQ Bio Active' Exchange Traded Fund (ETF).

According to Hyundai Asset Management, the UNICORN KOSDAQ Bio Active ETF, which was listed on this day, is a new ETF introduced approximately one year and six months after the 'UNICORN SK hynix Value Chain Active' ETF.

The UNICORN KOSDAQ Bio Active ETF uses the 'FnGuide K-Bio Balanced Index' as its benchmark and is a product focused on active management. The bio industry is categorized into four key sectors: ▲new drug development ▲CMO·CDMO (contract manufacturing·contract development and manufacturing) ▲aesthetic medicine ▲traditional pharmaceuticals. The ETF seeks to achieve excess returns by flexibly adjusting the weight of each sector according to market conditions.

Hyundai Asset Management believes that the KOSDAQ market is well-suited for active management, as performance can vary significantly depending on stock selection capabilities. Accordingly, rather than investing broadly across the entire KOSDAQ market, the company has chosen to focus on industries with high growth potential, such as the bio sector, as it considers this strategy to be more effective.

Cho Sanghyun, Head of Equity Management at Hyundai Asset Management, stated, "In the bio industry, not all companies rise together simply because the market is strong; performance varies widely depending on each company's technological capabilities, product portfolio, clinical stage, and potential for technology export. By applying the management expertise accumulated through operating public funds such as small and mid-cap funds and KOSDAQ venture funds to the ETF, we aim to deliver differentiated results."

This content was produced with the assistance of AI translation services.